Status:
COMPLETED
Chepetsa TB - Reducing TB Among HIV-Infected Malawians
Lead Sponsor:
Johns Hopkins University
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The specific aims of this project are: (1) to compare the impact of using the routine screening and GeneXpert algorithms for TB case detection on Tuberculosis (TB)- and HIV-related outcomes; (2) to co...
Detailed Description
HIV and tuberculosis (TB) are, along with malaria, the leading infectious causes of death worldwide and in sub-Saharan Africa.1 In 2008, there were 2 million deaths from AIDS and 1.8 million deaths fr...
Eligibility Criteria
Inclusion
- All HIV-infected men and women \> 18 years of age with newly diagnosed HIV at the 12 study clinics will be asked to participate in the study.
Exclusion
- Patients will be excluded from participation if they have a current diagnosis of TB and/or if they are currently taking IPT, TB treatment and/or ART.
- Patients will also be excluded from participation if they cannot speak English or Chichewa;
- if they have a language or hearing impairment; or
- if they are prisoners.
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2016
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT01450085
Start Date
September 1 2012
End Date
December 30 2016
Last Update
August 18 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Blantyre, Thyolo District, Malawi
2
Blantyre, Malawi